Search results
AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024
FOX21 Colorado Springs· 11 hours agoSociety (ATS) 2024 International Conference taking place May 12-22 in San Diego. "We look forward to presenting encouraging data from our Phase 2a COURSE trial in COPD with ...
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
Pharmaceutical Technology via Yahoo Finance· 2 days agoAccording to leading data and analytics company GlobalData’s...reduce exacerbations and manage the...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 7 days agoSanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance Paris, April 25, 2024 Sales growth of 6.7% at CER and business EPS(1) of €1.78 Dupixent sales up 24.9% to €2,835 million, on target to deliver ~€13bn in 2024
Amazon, AMD, and Super Micro Sing the Same Sad Song, and 5 Other Things to Know Before Markets Open.
Barrons.com· 8 hours agoTesla takes action amid slowing growth at fast-charging stations, Walmart unveils premium...
RSV vaccine boosts Monroe County's Sanofi Pasteur
WFMZ Eastern Pennsylvania and Western New Jersey· 6 days agoSanofi, a pharmaceutical company with Monroe County operations, reported a 2.4% gain in first-quarter revenue on Thursday, as sales of vaccines and the...
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024
WTNH-TV New Haven· 3 days agoTheravance Biopharma, Inc. (NASDAQ: TBPH) will report its first quarter 2024 financial results and provide a business update after market close on Monday, May 13, 2024. An accompanying conference ...
Foresee Pharmaceuticals Announces First Subject Dosed in its First-in-Human Clinical Trial of FP-020
WTNH-TV New Haven· 2 days agoForesee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been...
Plant-based diet may reduce risk of emphysema among smokers - UPI.com
UPI· 2 days agoCurrent and former smokers might lower their risk for emphysema if they adopt a highly nutritional...
ResMed director Karen Drexler sells company shares worth over $91k By Investing.com
Investing.com· 1 day agoKaren Drexler, a director at ResMed Inc. (NYSE:RMD), a company specializing in medical devices and...
Novo’s Blockbuster Ozempic Among FTC’s Latest Patent Targets
Bloomberg Law· 1 day agoOzempic and Victoza are among 20 branded drugs the Federal Trade Commission is targeting as it challenges more than 300 “junk patent listings” in the FDA’s registry of approved drugs in an effort ...